Bristol-Myers touts lung cancer breakthrough, but critics cry foul
February 05, 2018 at 12:02 PM EST
The drugmaker says its findings advanced the scientific understanding of how to treat lung cancer, but critics say a major overhaul of the clinical trial design sullied the results.
